EP 1064003 A1 20010103 - NEUROTROPHIC PROPERTIES OF IPGS AND IPG ANALOGUES
Title (en)
NEUROTROPHIC PROPERTIES OF IPGS AND IPG ANALOGUES
Title (de)
NEUROTROPISCHE EIGENSCHAFTEN DER INOSITOLPHOSPHOGLYCANE UND DEREN ANALOGE
Title (fr)
PROPRIETES NEUROTROPHIQUES DES IPG AND ANALOGUES D'IPG
Publication
Application
Priority
- GB 9803847 W 19981221
- GB 9801899 A 19980129
Abstract (en)
[origin: WO9938516A1] Inositolphosphoglycans (IPGs) or inositol-containing IPG analogues can be used to specifically cause neuron proliferation or neuron differentiation, and in particular neurite outgrowth. P-type IPGs or chiro-inositol containing analogues cause neurite outgrowth and A-type IPGs or myo-inositol containing analogues cause neuron proliferation. Compositions comprising these agents and their medical uses are also disclosed.
IPC 1-7
IPC 8 full level
A61K 31/70 (2006.01); A61K 31/7028 (2006.01); A61K 31/7034 (2006.01); A61P 21/00 (2006.01); A61P 25/00 (2006.01); A61P 25/28 (2006.01); C07H 15/207 (2006.01)
CPC (source: EP)
A61K 31/7034 (2013.01); A61K 31/7048 (2013.01); A61P 21/00 (2017.12); A61P 25/00 (2017.12); A61P 25/28 (2017.12)
Citation (search report)
See references of WO 9938516A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9938516 A1 19990805; AU 1770899 A 19990816; CA 2318584 A1 19990805; EP 1064003 A1 20010103; GB 9801899 D0 19980325; JP 2002501899 A 20020122
DOCDB simple family (application)
GB 9803847 W 19981221; AU 1770899 A 19981221; CA 2318584 A 19981221; EP 98962574 A 19981221; GB 9801899 A 19980129; JP 2000529249 A 19981221